This NDC is on FDA's drug shortage list (posted Feb 20, 2018)

Product Information

LIDOCAINE HCL 1% 50 MG/5 ML VIAL is a generic product labeled by Eugia US LLC, priced at $0.3705 per ML under NDC 55150016205. Its NADAC has been published 217 times since Sep 21, 2022.

FDA first approved this application on Mar 14, 2013. Its Orange Book therapeutic-equivalence code is AP.

LIDOCAINE HCL 1% 50 MG/5 ML VIAL

Lidocaine Hydrochloride
$0.3705per ML

Strength

10 mg/mL

Manufacturer

Eugia US LLC

NDC

55150016205

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL

Effective Date

10/21/2026

Active Ingredients

LIDOCAINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203082

FDA Approved

3/14/2013

TE Code

AP

On Market Since

3/14/2013

Pharmacological Classes

Price Statistics

The NADAC for LIDOCAINE HCL 1% 50 MG/5 ML VIAL has been published 217 times since Sep 21, 2022, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3705 per ML
All-time high$0.6414 (Mar 11, 2026)
All-time low$0.3221 (Aug 19, 2026)
52-week high$0.6414
52-week low$0.3221
Median price$0.4430
Average price$0.4650
Largest weekly change+33.2% (Feb 22, 2023)
Weeks tracked217
Tracking sinceSep 21, 2022

Price History

1W

0.0%

1M

+11.3%

3M

+15.0%

6M

-32.3%

1Y

-37.2%

3Y

-13.4%

5Y

N/A

All

-9.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LIDOCAINE HCL 1% 50 MG/5 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% 50 MG/5 ML VIAL, manufactured by Eugia US LLC, is $0.3705 per ML (NDC 55150016205), effective Nov 11, 2026.

How has the price of LIDOCAINE HCL 1% 50 MG/5 ML VIAL changed over time?

Over the history we have for it, the NADAC for LIDOCAINE HCL 1% 50 MG/5 ML VIAL has declined 9.8%. It has been tracked across 217 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% 50 MG/5 ML VIAL?

Since Sep 21, 2022, the NADAC for LIDOCAINE HCL 1% 50 MG/5 ML VIAL has ranged from a low of $0.3221 (Aug 19, 2026) to a high of $0.6414 (Mar 11, 2026), with a median of $0.4430 per ML.

Are there cheaper alternatives to LIDOCAINE HCL 1% 50 MG/5 ML VIAL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0688 per ML — about 81% below LIDOCAINE HCL 1% 50 MG/5 ML VIAL.

Who manufactures LIDOCAINE HCL 1% 50 MG/5 ML VIAL?

LIDOCAINE HCL 1% 50 MG/5 ML VIAL (NDC 55150016205) is labeled by Eugia US LLC, and CMS classifies it as a generic product.

Is LIDOCAINE HCL 1% 50 MG/5 ML VIAL in shortage?

Yes — NDC 55150016205 is currently listed in FDA's drug shortage database (posted Feb 20, 2018).